# Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma

> **NCT04973098** · PHASE1 · UNKNOWN · sponsor: **Peking University** · enrollment: 13 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** CT0181 Cells

## Key facts

- **NCT ID:** NCT04973098
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-05
- **Primary completion:** 2022-08
- **Final completion:** 2023-06
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2021-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973098, "Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04973098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*